Lindsay Bealor Greenleaf talks to HealthLeaders Media about the pitfalls of requiring list price disclosure in TV ads
"Simply disclosing a drug's list price in advertisements would be misleading because list prices don't account for rebates and negotiated discounts provided to pharmacy benefits managers and other players in the complex supply chain," Lindsay Bealor Greenleaf, director at ADVI Health, told HealthLeaders. "Adding to the confusion is that patients' out-of-pocket costs will vary depending on the benefit design of an individual's health plan."
[el-text]
Written by Steven Porter
***excerpt***
“Simply disclosing a drug’s list price in advertisements would be misleading because list prices don’t account for rebates and negotiated discounts provided to pharmacy benefits managers and other players in the complex supply chain,” Lindsay Bealor Greenleaf, director at ADVI Health, told HealthLeaders. “Adding to the confusion is that patients’ out-of-pocket costs will vary depending on the benefit design of an individual’s health plan.”
***end excerpt***
***
[/el-text]
View full article here
Reach out
Own your edge
We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.